NATCO PHARMA LIMITED
Last · NSE₹843.25-5.95 (-0.70%)stale · yahoo · 220h ago
MA10MA20MA50
Market cap₹153.8B179.1M sh
P/E · TTM13.2fwd 17.8 · eps 63.86
Beta0.18vs S&P 500
Div yield0.77%annual · TTM
52w range
₹789.00₹1226.80
Volume472.7Ksession
Issuer
Legal nameNATCO PHARMA LIMITED
HQIndia (IN)
ListingIN NATCOPHARM
ISININE987B01026
SectorHealthcare
IndustryPharmaceuticals
CurrencyINR
Entity registrynse:NATCOPHARM
Websitewww.natcopharma.co.in
Employees4,199
AddressNATCO Pharma Ltd. NATCO House 500034, Hyderabad +91 40 2354 7532
| Revenue | ₹4.1B |
|---|---|
| Net income | ₹1.9B |
| Net margin | 45.2% |
Loading chart…
Upcoming earnings
THU.12NOV
11:00 AM UTC+1
Period
Sep 2026
Est. EPS
$8.04
Est. revenue
7.6B
Earnings transcripts
- Issuer webcast
Audio File
NATCO PHARMA LIMITED
- Issuer IR
Concall Transcripts
NATCO PHARMA LIMITED
- Issuer IR
2025 earnings call transcript
NATCO PHARMA LIMITED
- Issuer IR
2025 earnings call transcript
NATCO PHARMA LIMITED
- Issuer IR
2025 earnings call transcript
NATCO PHARMA LIMITED
- Issuer IR
2025 earnings call transcript
NATCO PHARMA LIMITED
Documents
FormReporting forFiledFlags
Showing 5 of 206 filings